| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |